Thrombosis is a hallmark of life-threatening diseases, such as myocardial infarction, stroke or venous thromboembolism representing major causes of death in the western civilization. In 2014 the Special Research Program SFB-F54 (“Cellular Mediators Linking Inflammation and Thrombosis”) was launched at the Medical University Vienna financed by the Austrian Science Fund (FWF), which comprises a network of eight research groups that are focusing on molecular and cellular links between inflammation and thrombotic diseases to provide a new view of thrombosis integrating the role of inflammatory processes thereby building up new strategies for therapeutic interventions.

Our Special Research Program SFB-F54 has been extended for a second funding phase from 2018 - 2022.



“From lipids to thrombosis: translational research targeting HDL and platelet function”


News and recent publications


Blood Advances "IκB kinase 2 is not essential for platelet activation"


We are happy to announce that Barbara Thaler (Wojta-group) was selected as researcher of the month for her recently published work on „Differential expression of Plg-RKT and its effects on migration of proinflammatory monocyte and macrophage..


During ESC Congress, the Working Group on Pulmonary Circulation and Right Ventricular Function held its General Assembly to present achieved and upcoming activities to its members. This was also the opportunity to award 4 to 6 young researchers..